IBDEI04H ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1670,2)
 ;;=^5004173
 ;;^UTILITY(U,$J,358.3,1671,0)
 ;;=R56.00^^11^147^23
 ;;^UTILITY(U,$J,358.3,1671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1671,1,3,0)
 ;;=3^Simple Febrile Convulsions
 ;;^UTILITY(U,$J,358.3,1671,1,4,0)
 ;;=4^R56.00
 ;;^UTILITY(U,$J,358.3,1671,2)
 ;;=^5019522
 ;;^UTILITY(U,$J,358.3,1672,0)
 ;;=R56.9^^11^147^9
 ;;^UTILITY(U,$J,358.3,1672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1672,1,3,0)
 ;;=3^Convulsions,Unspec
 ;;^UTILITY(U,$J,358.3,1672,1,4,0)
 ;;=4^R56.9
 ;;^UTILITY(U,$J,358.3,1672,2)
 ;;=^5019524
 ;;^UTILITY(U,$J,358.3,1673,0)
 ;;=R42.^^11^147^10
 ;;^UTILITY(U,$J,358.3,1673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1673,1,3,0)
 ;;=3^Dizziness and Giddiness
 ;;^UTILITY(U,$J,358.3,1673,1,4,0)
 ;;=4^R42.
 ;;^UTILITY(U,$J,358.3,1673,2)
 ;;=^5019450
 ;;^UTILITY(U,$J,358.3,1674,0)
 ;;=R50.81^^11^147^12
 ;;^UTILITY(U,$J,358.3,1674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1674,1,3,0)
 ;;=3^Fever in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,1674,1,4,0)
 ;;=4^R50.81
 ;;^UTILITY(U,$J,358.3,1674,2)
 ;;=^5019508
 ;;^UTILITY(U,$J,358.3,1675,0)
 ;;=R50.82^^11^147^20
 ;;^UTILITY(U,$J,358.3,1675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1675,1,3,0)
 ;;=3^Postprocedural Fever
 ;;^UTILITY(U,$J,358.3,1675,1,4,0)
 ;;=4^R50.82
 ;;^UTILITY(U,$J,358.3,1675,2)
 ;;=^5019509
 ;;^UTILITY(U,$J,358.3,1676,0)
 ;;=Z13.6^^11^147^21
 ;;^UTILITY(U,$J,358.3,1676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1676,1,3,0)
 ;;=3^Screening for Cardiovascular Disorders
 ;;^UTILITY(U,$J,358.3,1676,1,4,0)
 ;;=4^Z13.6
 ;;^UTILITY(U,$J,358.3,1676,2)
 ;;=^5062707
 ;;^UTILITY(U,$J,358.3,1677,0)
 ;;=I25.2^^11^148^3
 ;;^UTILITY(U,$J,358.3,1677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1677,1,3,0)
 ;;=3^Old MI
 ;;^UTILITY(U,$J,358.3,1677,1,4,0)
 ;;=4^I25.2
 ;;^UTILITY(U,$J,358.3,1677,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,1678,0)
 ;;=Z95.2^^11^148^6
 ;;^UTILITY(U,$J,358.3,1678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1678,1,3,0)
 ;;=3^Presence of Prosthetic Heart Valve
 ;;^UTILITY(U,$J,358.3,1678,1,4,0)
 ;;=4^Z95.2
 ;;^UTILITY(U,$J,358.3,1678,2)
 ;;=^5063670
 ;;^UTILITY(U,$J,358.3,1679,0)
 ;;=Z95.1^^11^148^4
 ;;^UTILITY(U,$J,358.3,1679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1679,1,3,0)
 ;;=3^Presence of Aortocoronary Bypass Graft
 ;;^UTILITY(U,$J,358.3,1679,1,4,0)
 ;;=4^Z95.1
 ;;^UTILITY(U,$J,358.3,1679,2)
 ;;=^5063669
 ;;^UTILITY(U,$J,358.3,1680,0)
 ;;=Z98.61^^11^148^1
 ;;^UTILITY(U,$J,358.3,1680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1680,1,3,0)
 ;;=3^Coronary Angioplasty Status
 ;;^UTILITY(U,$J,358.3,1680,1,4,0)
 ;;=4^Z98.61
 ;;^UTILITY(U,$J,358.3,1680,2)
 ;;=^5063742
 ;;^UTILITY(U,$J,358.3,1681,0)
 ;;=Z95.2^^11^148^7
 ;;^UTILITY(U,$J,358.3,1681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1681,1,3,0)
 ;;=3^Presence of Prosthetic Heart Valve
 ;;^UTILITY(U,$J,358.3,1681,1,4,0)
 ;;=4^Z95.2
 ;;^UTILITY(U,$J,358.3,1681,2)
 ;;=^5063670
 ;;^UTILITY(U,$J,358.3,1682,0)
 ;;=Z95.3^^11^148^8
 ;;^UTILITY(U,$J,358.3,1682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1682,1,3,0)
 ;;=3^Presence of Xenogenic Heart Valve
 ;;^UTILITY(U,$J,358.3,1682,1,4,0)
 ;;=4^Z95.3
 ;;^UTILITY(U,$J,358.3,1682,2)
 ;;=^5063671
 ;;^UTILITY(U,$J,358.3,1683,0)
 ;;=Z95.4^^11^148^5
 ;;^UTILITY(U,$J,358.3,1683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1683,1,3,0)
 ;;=3^Presence of Heart Valve Replacement NEC
 ;;^UTILITY(U,$J,358.3,1683,1,4,0)
 ;;=4^Z95.4
 ;;^UTILITY(U,$J,358.3,1683,2)
 ;;=^5063672
 ;;^UTILITY(U,$J,358.3,1684,0)
 ;;=Z79.01^^11^148^2
 ;;^UTILITY(U,$J,358.3,1684,1,0)
 ;;=^358.31IA^4^2
